1
|
Helbitz A, Haris M, Younsi T, Romer E, Ginks W, Raveendra K, Hayward C, Shuweihdi F, Larvin H, Cameron A, Wu J, Buck B, Lip GYH, Nadarajah R, Gale CP. Prediction of atrial fibrillation after a stroke event: A systematic review with meta-analysis. Heart Rhythm 2025:S1547-5271(25)00095-5. [PMID: 39864482 DOI: 10.1016/j.hrthm.2025.01.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Revised: 01/08/2025] [Accepted: 01/20/2025] [Indexed: 01/28/2025]
Abstract
BACKGROUND Detecting atrial fibrillation (AF) after stroke is a key component of secondary prevention, but indiscriminate prolonged cardiac monitoring is costly and burdensome. Multivariable prediction models could be used to inform selection of patients. OBJECTIVE This study aimed to determine the performance of available models for predicting AF after a stroke. METHODS We searched for studies of multivariable models that were derived, validated, or augmented for prediction of AF in patients with a stroke, using MEDLINE and Embase from inception through September 20, 2024. Discrimination measures for tools with C statistic data from ≥3 cohorts were pooled by bayesian meta-analysis, with heterogeneity assessed through a 95% prediction interval. The risk of bias was assessed with the Prediction model Risk Of Bias Assessment tool (PROBAST). RESULTS We included 75 studies with 58 prediction models; 66% had a high risk of bias. Fifteen multivariable models were eligible for meta-analysis. Three models showed excellent discrimination: SAFE (C statistic, 0.856; 95% confidence interval [CI], 0.796-0.916), SURF (0.815; 95% CI, 0.728-0.893), and iPAB (0.888; 95% CI, 0.824-0.957). Excluding high-bias studies, only SAFE showed excellent discrimination (0.856; 95% CI 0.800-0.915). No model showed excellent discrimination when limited to external validation or studies with ≥100 AF events. No clinical impact studies were found. CONCLUSION Three of the 58 identified multivariable prediction models for AF after stroke demonstrated excellent statistical performance on meta-analysis. However, prospective validation is required to understand the effectiveness of these models in clinical practice before they can be recommended for inclusion in clinical guidelines.
Collapse
Affiliation(s)
- Anna Helbitz
- Faculty of Medicine and Health, University of Leeds, Leeds, United Kingdom.
| | - Mohammad Haris
- Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; Leeds Institute of Data Analytics, University of Leeds, Leeds, United Kingdom
| | - Tanina Younsi
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
| | - Elizabeth Romer
- Department of Cardiology, Airedale NHS Foundation Trust, Keighley, United Kingdom
| | - William Ginks
- Faculty of Medicine and Health, University of Leeds, Leeds, United Kingdom
| | | | - Chris Hayward
- Leeds Institute of Data Analytics, University of Leeds, Leeds, United Kingdom
| | - Farag Shuweihdi
- School of Dentistry, University of Leeds, Leeds, United Kingdom
| | - Harriet Larvin
- Wolfson Institute of Population Health, Queen Mary, University of London, London, United Kingdom
| | - Alan Cameron
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom
| | - Jianhua Wu
- Wolfson Institute of Population Health, Queen Mary, University of London, London, United Kingdom
| | - Brian Buck
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
| | - Gregory Y H Lip
- Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Department of Clinical Medicine, Danish Center for Health Services Research, Aalborg University, Aalborg, Denmark
| | - Ramesh Nadarajah
- Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; Leeds Institute of Data Analytics, University of Leeds, Leeds, United Kingdom; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
| | - Chris P Gale
- Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; Leeds Institute of Data Analytics, University of Leeds, Leeds, United Kingdom; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
| |
Collapse
|
2
|
Kashou AH, Adedinsewo DA, Siontis KC, Noseworthy PA. Artificial Intelligence-Enabled ECG: Physiologic and Pathophysiologic Insights and Implications. Compr Physiol 2022; 12:3417-3424. [PMID: 35766831 PMCID: PMC9795459 DOI: 10.1002/cphy.c210001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Advancements in machine learning and computing methods have given new life and great excitement to one of the most essential diagnostic tools to date-the electrocardiogram (ECG). The application of artificial intelligence-enabled ECG (AI-ECG) has resulted in the ability to identify electrocardiographic signatures of conventional and unique variables and pathologies, giving way to tremendous clinical potential. However, what these AI-ECG models are detecting that the human eye is missing remains unclear. In this article, we highlight some of the recent developments in the field and their potential clinical implications, while also attempting to shed light on the physiologic and pathophysiologic features that enable these models to have such high diagnostic yield. © 2022 American Physiological Society. Compr Physiol 12:3417-3424, 2022.
Collapse
Affiliation(s)
- Anthony H Kashou
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
| | | | | | - Peter A Noseworthy
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
3
|
Ozersari S, Ünal B, Kemal Çabuk A, Eren Hazir K, Çağri Şimşek E, Ekmekci C, Küçükukur M, Betül Paköz Z, Günay S, Sari C. The prognostic value of P-wave dispersion and left atrial functions assessed with three-dimensional echocardiography in patients with cirrhosis. Eur J Gastroenterol Hepatol 2021; 33:1441-1450. [PMID: 33741802 DOI: 10.1097/meg.0000000000002129] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
BACKGROUND Cirrhotic cardiomyopathy (CCM) is a well-known entity. The aim of this study was to compare left atrial three-dimensional (3D) volume and P-wave dispersion (PWd) in patients with cirrhosis and a healthy population. The secondary purpose was to assess the left phasic volumes and reservoir functions with 3D echocardiography for the prediction of an increased risk of poor outcomes in patients with cirrhosis. METHODS The study included 50 patients with cirrhosis and 43 healthy control subjects without atrial fibrillation. All patients were assessed with two-dimensional (2D), 3D, and tissue Doppler transthoracic echocardiography. The PWd was calculated using a 12-lead surface electrocardiogram (ECG). Cirrhotic patients were followed up for 2.5 years for the evaluation of poor outcomes and the development of atrial fibrillation. RESULTS Patients with cirrhosis were observed to have significantly higher left atrial phasic volumes such as minimal left atrial volume (3D-LAVmin, P = 0.004) and indexed LAVmin (3D-LAVImin, P = 0.0001), and significantly decreased left atrial reservoir functions such as left atrial emptying volume (3D-LAEV, P = 0,001), left atrial ejection fraction (3D-LAEF, P = 0,001) on 3D echocardiography. PWd was determined to be significantly longer in the cirrhotic group compared with the control group (P = 0.003). In the 2.5-year follow-up period, poor outcomes occurred in 34 patients (22 patients died, six patients had liver transplantation, six patients developed atrial fibrillation/AHRE episodes). In Cox regression analysis, the MELD score (HR, 1.16 (1.06-1.26), P = 0.001) and 3D-LAVImin (HR, 0.95 (0.86-1.00), P = 0.040) were significantly associated with all-cause mortality. Cirrhotic patients with LAVImin of >15 ml/m2 were seen to have poor survival (long rank P = 0.033). CONCLUSION The results of this study showed that patients with cirrhosis had higher left atrial volume, longer PWd and worse diastolic functions compared with the control group. Higher disease severity scores were associated with left atrial function and volume. In addition, left atrial volume measured with 3DE was a strong predictor of future adverse events, and minimal left atrial volumes had a higher prognostic value than any other left atrial function indices.
Collapse
Affiliation(s)
| | - Bariş Ünal
- Cardiology, Tepecik Education and Research Hospital, İzmir, Turkey
| | - Ali Kemal Çabuk
- Cardiology, Tepecik Education and Research Hospital, İzmir, Turkey
| | | | | | - Cenk Ekmekci
- Cardiology, Tepecik Education and Research Hospital, İzmir, Turkey
| | - Murat Küçükukur
- Cardiology, Tepecik Education and Research Hospital, İzmir, Turkey
| | | | | | - Cenk Sari
- Cardiology, Tepecik Education and Research Hospital, İzmir, Turkey
| |
Collapse
|
4
|
Acampa M, Lazzerini PE, Guideri F, Tassi R, Andreini I, Domenichelli C, Cartocci A, Martini G. Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke. Heart Lung Circ 2019; 28:1664-1669. [DOI: 10.1016/j.hlc.2018.10.020] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2018] [Revised: 09/19/2018] [Accepted: 10/08/2018] [Indexed: 01/30/2023]
|
5
|
Acampa M, Lazzerini PE, Martini G. Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers. Front Neurol 2018; 9:469. [PMID: 29971041 PMCID: PMC6018106 DOI: 10.3389/fneur.2018.00469] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2018] [Accepted: 05/31/2018] [Indexed: 01/18/2023] Open
Abstract
Recently, atrial cardiopathy has emerged as possible pathogenic mechanism in cryptogenic stroke and many electrocardiographic (ECG) markers have been proposed in order to detect an altered atrial substrate at an early stage. The autonomic nervous system (ANS) plays a well-known role in determining significant and heterogeneous electrophysiological changes of atrial cardiomyocytes, that promote atrial fibrillation episodes in cardioembolic stroke. Conversely, the role of ANS in atrial cardiopathy and cryptogenic stroke is less known, as well as ANS effects on ECG markers of atrial dysfunction. In this paper, we review the evidence linking ANS dysfunction and atrial cardiopathy as a possible pathogenic factor in cryptogenic stroke.
Collapse
Affiliation(s)
- Maurizio Acampa
- Stroke Unit, Department of Neurological and Neurosensorial Sciences, Azienda Ospedaliera Universitaria Senese, "Santa Maria alle Scotte" General Hospital, Siena, Italy
| | - Pietro E Lazzerini
- Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy
| | - Giuseppe Martini
- Stroke Unit, Department of Neurological and Neurosensorial Sciences, Azienda Ospedaliera Universitaria Senese, "Santa Maria alle Scotte" General Hospital, Siena, Italy
| |
Collapse
|